Detalhe da pesquisa
1.
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Am J Gastroenterol
; 118(7): 1237-1247, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36716287
2.
Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease.
Gastroenterology
; 157(2): 432-439.e1, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953614
3.
MRI features indicative of permanent colon damage in ulcerative colitis: an exploratory study.
J Crohns Colitis
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767057
4.
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Therap Adv Gastroenterol
; 17: 17562848231221713, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187926
5.
Predictors of bowel damage in the long-term progression of Crohn's disease.
World J Clin Cases
; 10(33): 12208-12220, 2022 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36483818
6.
Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
Aliment Pharmacol Ther
; 53(9): 1021-1029, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715177
7.
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study.
Aliment Pharmacol Ther
; 53(12): 1277-1288, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962482
8.
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu.
J Clin Med
; 10(19)2021 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34640421
9.
Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn's Disease.
J Crohns Colitis
; 14(8): 1074-1081, 2020 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32080712
10.
Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease.
Aliment Pharmacol Ther
; 51(9): 870-879, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181930
11.
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
United European Gastroenterol J
; 8(9): 1056-1066, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723069
12.
JAK Inhibition: The Most Promising Agents in the IBD Pipeline?
Curr Pharm Des
; 25(1): 32-40, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30950344
13.
Tofacitinib for the treatment of ulcerative colitis.
Expert Rev Clin Immunol
; 14(11): 881-892, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30285500
14.
Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease.
Immunotherapy
; 10(14): 1203-1217, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296868
15.
Persistent damage on magnetic resonance enterography in patients with Crohn's disease in endoscopic remission.
Aliment Pharmacol Ther
; 48(11-12): 1232-1241, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30345577